Live Breaking News & Updates on Sanofi

Stay informed with the latest breaking news from Sanofi on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sanofi and stay connected to the pulse of your community

Sanofi India: Sanofi looks for accelerated growth in India; plans fast-tracking of product pipeline

Sanofi, a leading French pharmaceutical company, aims to expand its presence in the Indian market by introducing new drugs, enhancing localization efforts, and collaborating with domestic firms. Managing Director Rodolfo Hrosz highlights the significant growth potential in India and emphasizes the company's focus on addressing the diabetes segment.

France , India , French , Rodolfo-hrosz , Cipla , Sanofi-india-managing-director-rodolfo-hrosz , Healthcare-india , Sanofi-india , Sanofi , Hrosz , Sanofi-healthcare-india , Soliqua

Sanofi says to reach settlement on Zantac lawsuits in US

French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac.

Canada , United-kingdom , Vietnam , Republic-of , Delaware , United-states , Long-chau , Han-i , Paris , France-general- , France , British

Sanofi gets nod for new polio vaccine in India

To ensure that there is no interruption to the availability of IPV vaccines, the French firm has already obtained approvals for IMOVAX-Polio.

France , India , Hyderabad , Andhra-pradesh , French , Sanofi-healthcare-india-pvt-ltd , Serum-institute-of-india , Inactivated-polio-vaccine , Sanofi-india , Serum-institute , Sanofi

Sanofi gets nod for injectable Polio vaccine

The announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a potential shortage in the country.

India , France , French , Sanofi , Vaccine , Polio-vaccine , Polio , Vaccine-doses ,

polio vaccine: Polio vaccine shortage looms over India with Sanofi plants' shutdown

An impending crisis looms over India's supply of injectable poliomyelitis vaccine (IPV) as French drugmaker Sanofi has shut down its manufacturing plants in the country, halting production of its IPV brand ShanIPV in December 2023. Sanofi's closure has raised concerns about disruptions in India's polio eradication efforts, as it catered to over 80% of the country's IPV dose requirements.

Pune , Maharashtra , India , Medchal , Andhra-pradesh , France , Telangana , French , Sanofi-pasteur , Serum-institute-of-india , India-universal-immunization-programme , Serum-institute

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did not disclose the financial terms of the deal. The agreement, which still needs to be finalized, will resolve most of the lawsuits against the French pharmaceutical company in U.S. state courts, with the exception of Delaware where the majority of the cases are pending.

Delaware , United-states , Chris-reese , Dietrich-knauthediting , Reuters , Sanofi , Oehringer-ingelheim , Ennifer-moore , Ancer , Antac , Elaware-superior-court , Laintiffs

Five Oceans Advisors Makes New $235,000 Investment in Sanofi (NASDAQ:SNY)

Five Oceans Advisors purchased a new stake in Sanofi (NASDAQ:SNY – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,733 shares of the company’s stock, valued at approximately $235,000. A number of other institutional investors also recently modified their […]

United-states , Morgan-stanley , Goldman-sachs-group-inc , Envestnet-asset-management-inc , Perceptive-advisors , Arrowstreet-capital-limited-partnership , Exchange-commission , Jpmorgan-chase-co , Five-oceans-advisors , Free-report , Capital-limited-partnership

AstraZeneca-Sanofi Beyfortus approved in Japan for prevention of RSV disease in infants

Cambridge: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by...

Nagasaki , Yamagata , Japan , China , Japanese , Hiroyuki-moriuchi , Iskra-reic , Astrazeneca , European-union , Japanese-ministry-of-health , Nagasaki-university-graduate-school-of-biomedical-sciences , Head-of-department-pediatrics

Sanofi: Cipla to distribute Sanofi's CNS product line in India

According to the joint statement, Cipla will utilise its skills and solid India-wide network of distributors, institutions and market outreach programmes to expand access to these treatments for patients. Meanwhile, Sanofi India will continue to own, import, and manufacture its entire range of CNS products across plants in India and abroad.

India , Sanofi-healthcare-india-private , Cipla , Sanofi-india , Sanofi-healthcare-india-private-limited , Central-nervous-system , Sanofi , Distribution , Cns , Partnership , Marketing

Lantz Financial LLC Reduces Stock Position in Sanofi (NASDAQ:SNY)

Lantz Financial LLC trimmed its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 13.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,903 shares of the company’s stock after selling 764 shares during the period. Lantz Financial […]

United-states , Cambridge , Cambridgeshire , United-kingdom , Lantz-financial , Fairfield-bush , Exchange-commission , York-mellon-corp , Morgan-stanley , Dimensional-fund-advisors , Cambridge-investment-research-advisors-inc